This is a preview of subscription content, log in via an institution to check access.
References
Guinan EC . Acquired aplastic anemia in childhood. Hematol Oncol Clin North Am 2009; 23: 171–191.
Bacigalupo A, Socie' G, Lanino E, Prete A, Locatelli F, Locasciulli A et al. Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA Working Party. Haematologica 2010; 95: 976–982.
Marsh JC, Kulasekararaj AG . Management of the refractory aplastic anemia patient: what are the options? Blood 2013; 122: 3561–3567.
Yoshimi A, Kojima S, Taniguchi S, Hara J, Matsui T, Takahashi Y, Azuma H et al. Unrelated cord blood transplantation for severe aplastic anemia. Biol Blood Marrow Transplant 2008; 14: 1057–1063.
Luznik L, O'Donnell PV, Symons HJ, Chen AR, Leffell MS, Zahurak M et al. HLA haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. Biol Blood Marrow Transplant 2008; 14: 641–650.
Fuchs EJ . Human leukocyte antigen-haploidentical stem cell transplantation using T-cell-replete bone marrow grafts. Curr Opin Hematol 2012; 19: 440–447.
Bolaños-Meade J, Fuchs EJ, Luznik L, Lanzkron SM, Gamper CJ, Jones RJ et al. HLA haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease. Blood 2012; 120: 4285–4291.
Raj K, Pagliuca A, Bradstock K, Noriega V, Potter V, Streetly M et al. Peripheral blood hematopoietic stem cells for transplantation of hematological diseases from related, haploidentical donors after reduced-intensity conditioning. Biol Blood Marrow Transplant 2014; 20: 890–895.
Ciceri F, Lupo-Stanghellini MT, Korthof ET . Haploidentical transplantation in patients with acquired aplastic anemia. Bone Marrow Transplant 2013; 48: 183–185.
Castagna L, Crocchiolo R, Furst S, Bramanti S, El Cheikh J, Sarina B et al. Bone marrow compared with peripheral blood stem cells for haploidentical transplantation with a nonmyeloablative conditioning regimen and post-transplantation cyclophosphamide. Biol Blood Marrow Transplant 2014; 20: 724–729.
Acknowledgements
NG designed the research and wrote the manuscript; DC designed the research; SKS designed the research and helped in writing the manuscript; VK and MD wrote the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Gupta, N., Choudhary, D., Sharma, S. et al. Haploidentical hematopoietic SCT for acquired severe aplastic anemia using post-transplant high-dose CY. Bone Marrow Transplant 50, 155–156 (2015). https://doi.org/10.1038/bmt.2014.222
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2014.222
- Springer Nature Limited
This article is cited by
-
Idiopathic Aplastic anemia: Indian Perspective
Indian Journal of Hematology and Blood Transfusion (2022)
-
Clinical evaluation of haploidentical hematopoietic combined with human umbilical cord-derived mesenchymal stem cells in severe aplastic anemia
European Journal of Medical Research (2018)
-
Unmanipulated haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide in a patient with paroxysmal nocturnal hemoglobinuria and secondary aplastic anemia
Bone Marrow Transplantation (2016)
-
Haploidentical BMT and post-transplant Cy for severe aplastic anemia: a multicenter retrospective study
Bone Marrow Transplantation (2015)